Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients With Type 2 Diabetes
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Epidemiology
Reference37 articles.
1. Pharmacologic glycemic management of type 2 diabetes in adults.;Lipscombe;Can J Diabetes,2018
2. Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.;Shigeoka;J Diabetes Investig,2020
3. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth.;Nomiyama;Diabetes,2014
4. Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters.;Lu;J Res Med Sci,2013
5. Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor, CD26.;Gonzalez-Gronow;Exp Cell Res,2005
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: a population-based cohort study;Diabetes & Metabolism;2024-08
2. Incretin-based drugs decrease the incidence of prostate cancer in type 2 diabetics: A pooling-up analysis;Medicine;2024-05-17
3. Comparisons of New-Onset Prostate Cancer in Type 2 Diabetes Mellitus Exposed to Sglt2i, Dpp4i and Glp1: A Population-Based Cohort Study;2024
4. New-onset prostate cancer in type 2 diabetes mellitus exposed to the SGLT2I, DPP4I and GLP1a: A population-based cohort study;2023-11-27
5. Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment;Nutrients;2023-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3